Free Trial

Lachlan Brown Analyst Performance

Analyst at William Blair

Lachlan Brown is a stock analyst at William Blair across a range of sectors, covering 7 publicly traded companies. Over the past year, Lachlan Brown has issued 7 stock ratings, including buy and hold recommendations. While full access to Lachlan Brown's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lachlan Brown's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
8 Last 1 Years
Buy Recommendations
62.50% 5 Buy Ratings
Companies Covered
7 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy62.5%5 ratings
Hold37.5%3 ratings
Sell0.0%0 ratings

Out of 8 total stock ratings issued by Lachlan Brown at William Blair, the majority (62.5%) have been Buy recommendations, followed by 37.5% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
7 companies

Lachlan Brown, an analyst at William Blair, currently covers 7 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
4 companies
57.1%
Computer and Technology
2 companies
28.6%
Business Services
1 company
14.3%

Lachlan Brown of William Blair specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.

Coverage Industries

IndustryPercentage
COMP - SOFTWARE
2 companies
28.6%
MED - BIOMED/GENE
2 companies
28.6%
MED - DRUGS
2 companies
28.6%
BUSINESS SVCS
1 company
14.3%

Lachlan Brown's Ratings History at William Blair

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
SPS Commerce, Inc. stock logo
SPSC
SPS Commerce
4/16/2026Set Price Target$55.36$60.00Neutral
The Descartes Systems Group Inc. stock logo
DSGX
The Descartes Systems Group
4/16/2026Upgrade$72.60$90.00Buy
SPS Commerce, Inc. stock logo
SPSC
SPS Commerce
4/16/2026Downgrade$56.55$60.00Neutral
Eupraxia Pharmaceuticals Inc. stock logo
EPRX
Eupraxia Pharmaceuticals
3/23/2026Initiated Coverage$7.10Outperform
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
12/3/2025Initiated Coverage$30.43Outperform
Manhattan Associates, Inc. stock logo
MANH
Manhattan Associates
6/10/2025Downgrade$193.65$200.00Neutral
Harrow, Inc. stock logo
HROW
Harrow
6/10/2025Initiated Coverage$30.15Outperform
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
4/8/2025Initiated Coverage$6.30Outperform